180 related articles for article (PubMed ID: 22520517)
1. Rationale and design of a Global Rheumatic Heart Disease Registry: the REMEDY study.
Karthikeyan G; Zühlke L; Engel M; Rangarajan S; Yusuf S; Teo K; Mayosi BM
Am Heart J; 2012 Apr; 163(4):535-40.e1. PubMed ID: 22520517
[TBL] [Abstract][Full Text] [Related]
2. The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation.
Karthikeyan G; Connolly SJ; Ntsekhe M; Benz A; Rangarajan S; Lewis G; Yun Y; Sharma SK; Maklady F; Elghamrawy AE; Kazmi K; Cabral TTJ; Dayi H; Changsheng M; Gitura BM; Avezum A; Zuhlke L; Lwabi P; Haileamlak A; Ogah O; Chillo P; Paniagua M; ElSayed A; Dans A; Gondwe-Chunda L; Molefe-Baikai OJ; Gonzalez-Hermosillo JA; Hakim J; Damasceno A; Kamanzi ER; Musuku J; Davletov K; Connolly K; Mayosi BM; Yusuf S;
Am Heart J; 2020 Jul; 225():69-77. PubMed ID: 32474206
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics, Complications, and Treatment Practices in Patients With RHD: 6-Year Results From HP-RHD Registry.
Negi PC; Mahajan K; Rana V; Sondhi S; Mahajan N; Rathour S; Verma R; Dhiman A; Dev M; Rao S; Asotra S; Bhardwaj R; Ganju N; Kandoria A; Merwaha R; Sharma R; Kolte N; Kumar V R; Paul PK; Singh DP
Glob Heart; 2018 Dec; 13(4):267-274.e2. PubMed ID: 30197242
[TBL] [Abstract][Full Text] [Related]
4. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study).
Zühlke L; Engel ME; Karthikeyan G; Rangarajan S; Mackie P; Cupido B; Mauff K; Islam S; Joachim A; Daniels R; Francis V; Ogendo S; Gitura B; Mondo C; Okello E; Lwabi P; Al-Kebsi MM; Hugo-Hamman C; Sheta SS; Haileamlak A; Daniel W; Goshu DY; Abdissa SG; Desta AG; Shasho BA; Begna DM; ElSayed A; Ibrahim AS; Musuku J; Bode-Thomas F; Okeahialam BN; Ige O; Sutton C; Misra R; Abul Fadl A; Kennedy N; Damasceno A; Sani M; Ogah OS; Olunuga T; Elhassan HH; Mocumbi AO; Adeoye AM; Mntla P; Ojji D; Mucumbitsi J; Teo K; Yusuf S; Mayosi BM
Eur Heart J; 2015 May; 36(18):1115-22a. PubMed ID: 25425448
[TBL] [Abstract][Full Text] [Related]
5. Participation in research improves overall patient management: insights from the Global Rheumatic Heart Disease registry (REMEDY).
Prendergast EA; Perkins S; Engel ME; Cupido B; Francis V; Joachim A; Al Kebsi M; Bode-Thomas F; Damasceno A; Abul Fadl A; El Sayed A; Gitura B; Kennedy N; Ibrahim A; Mucumbitsi J; Adeoye AM; Musuku J; Okello E; Olunuga T; Sheta S; Mayosi BM; Zühlke LJ;
Cardiovasc J Afr; 2018 Mar/Apr 23; 29(2):98-105. PubMed ID: 29570206
[TBL] [Abstract][Full Text] [Related]
6. Clinical Outcomes in 3343 Children and Adults With Rheumatic Heart Disease From 14 Low- and Middle-Income Countries: Two-Year Follow-Up of the Global Rheumatic Heart Disease Registry (the REMEDY Study).
Zühlke L; Karthikeyan G; Engel ME; Rangarajan S; Mackie P; Cupido-Katya Mauff B; Islam S; Daniels R; Francis V; Ogendo S; Gitura B; Mondo C; Okello E; Lwabi P; Al-Kebsi MM; Hugo-Hamman C; Sheta SS; Haileamlak A; Daniel W; Goshu DY; Abdissa SG; Desta AG; Shasho BA; Begna DM; ElSayed A; Ibrahim AS; Musuku J; Bode-Thomas F; Yilgwan CC; Amusa GA; Ige O; Okeahialam B; Sutton C; Misra R; Abul Fadl A; Kennedy N; Damasceno A; Sani MU; Ogah OS; Elhassan TO; Mocumbi AO; Adeoye AM; Mntla P; Ojji D; Mucumbitsi J; Teo K; Yusuf S; Mayosi BM
Circulation; 2016 Nov; 134(19):1456-1466. PubMed ID: 27702773
[TBL] [Abstract][Full Text] [Related]
7. Health system costs of rheumatic heart disease care in South Africa.
Hellebo AG; Zuhlke LJ; Watkins DA; Alaba O
BMC Public Health; 2021 Jul; 21(1):1303. PubMed ID: 34217236
[TBL] [Abstract][Full Text] [Related]
8. Burden of disease and barriers to comprehensive care for rheumatic heart disease in South Africa: an updated systematic review protocol.
Murugasen S; Abdullahi LH; Moloi H; Wyber R; Abrams J; Watkins DA; Engel ME; Zühlke LJ
BMJ Open; 2023 Jun; 13(6):e073300. PubMed ID: 37263687
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and outcomes of Indian children enrolled in a rheumatic heart disease registry.
Mehta A; Saxena A; Juneja R; Ramakrishnan S; Gupta S; Kothari SS
Int J Cardiol; 2016 Nov; 222():1136-1140. PubMed ID: 27567391
[TBL] [Abstract][Full Text] [Related]
10. Long term outcomes in patients with RF/RHD: Eight-year follow-up of HP-RF/RHD (Himachal Pradesh Rheumatic Fever/Rheumatic Heart Disease) registry in a Northern Indian state.
Negi PC; Mahajan K; Kondal D; Asotra S; Sondhi S; Rao S; Ganju N; Kandoria A; Merwaha R; Sharma R
Int J Cardiol; 2021 Nov; 343():149-155. PubMed ID: 34520796
[TBL] [Abstract][Full Text] [Related]
11. The VALVAFRIC study: A registry of rheumatic heart disease in Western and Central Africa.
Kingué S; Ba SA; Balde D; Diarra MB; Anzouan-Kacou JB; Anisubia B; Damorou JM; Ndobo P; Menanga A; Kane A; Kakou-Guikahué M; Kenfack M; Metogo B; Chelo D; Yangnigni E; Tantchou C; Bertrand E; Monsuez JJ;
Arch Cardiovasc Dis; 2016 May; 109(5):321-9. PubMed ID: 26988837
[TBL] [Abstract][Full Text] [Related]
12. Gender differences in the epidemiology of Rheumatic Fever/Rheumatic heart disease (RF/RHD) patient population of hill state of northern India; 9 years prospective hospital based, HP-RHD registry.
Negi PC; Kandoria A; Asotra S; Ganju NK; Merwaha R; Sharma R; Mahajan K; Rao S
Indian Heart J; 2020; 72(6):552-556. PubMed ID: 33357644
[TBL] [Abstract][Full Text] [Related]
13. The personal and clinical impact of screen-detected maternal rheumatic heart disease in Uganda: a prospective follow up study.
Voleti S; Okello E; Murali M; Sarnacki R; Majwala A; Ssembatya R; Bakka O; Namisanvu H; Njeri A; Matovu A; DeStigter K; Sable C; Beaton A
BMC Pregnancy Childbirth; 2020 Oct; 20(1):611. PubMed ID: 33036571
[TBL] [Abstract][Full Text] [Related]
14. Incidence, prevalence and outcomes of rheumatic heart disease in South Africa: a systematic review protocol.
Zühlke L; Watkins D; Engel ME
BMJ Open; 2014 Jun; 4(6):e004844. PubMed ID: 24916089
[TBL] [Abstract][Full Text] [Related]
15. Newly diagnosed rheumatic heart disease among indigenous populations in the Pacific.
Mirabel M; Tafflet M; Noël B; Parks T; Axler O; Robert J; Nadra M; Phelippeau G; Descloux E; Cazorla C; Missotte I; Gervolino S; Barguil Y; Rouchon B; Laumond S; Jubeau T; Braunstein C; Empana JP; Marijon E; Jouven X
Heart; 2015 Dec; 101(23):1901-6. PubMed ID: 26537732
[TBL] [Abstract][Full Text] [Related]
16. Determining the impact of Benzathine penicillin G prophylaxis in children with latent rheumatic heart disease (GOAL trial): Study protocol for a randomized controlled trial.
Beaton A; Okello E; Engelman D; Grobler A; Scheel A; DeWyer A; Sarnacki R; Omara IO; Rwebembera J; Sable C; Steer A
Am Heart J; 2019 Sep; 215():95-105. PubMed ID: 31301533
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and pattern of rheumatic heart disease in the Nigerian savannah: an echocardiographic study.
Sani MU; Karaye KM; Borodo MM
Cardiovasc J Afr; 2007; 18(5):295-9. PubMed ID: 17957324
[TBL] [Abstract][Full Text] [Related]
18. Acute rheumatic fever and rheumatic heart disease: incidence and progression in the Northern Territory of Australia, 1997 to 2010.
Lawrence JG; Carapetis JR; Griffiths K; Edwards K; Condon JR
Circulation; 2013 Jul; 128(5):492-501. PubMed ID: 23794730
[TBL] [Abstract][Full Text] [Related]
19. Temporal trends of atrial fibrillation and/or rheumatic heart disease-related ischemic stroke, and anticoagulant use in Chinese population: An 8-year study.
Liu J; Wang Y; Guo W; Cheng Y; Zhang S; Wu B; Liu M
Int J Cardiol; 2021 Jan; 322():258-264. PubMed ID: 32814110
[TBL] [Abstract][Full Text] [Related]
20. Continuing Burden of Rheumatic Heart Disease in India.
Gupta R; Panwar RB; Sharma A; Panwar SR; Rao RS; Gupta BK
J Assoc Physicians India; 2020 Oct; 68(10):60-65. PubMed ID: 32978928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
